DVT (n = 9) | PE (n = 9) | AF (n = 13) | Total (n = 31) | |
---|---|---|---|---|
DISEASE INFORMATION: Duration of AF or last PE/DVT (years) | ||||
Range | 0.3 – 2.6 | 0.6 – 3 | 0.4 – 13 | 0.3 – 13 |
Mean | 1.3 | 1.2 | 5.8 | 3.1 |
TREATMENT INFORMATION | ||||
Name(s) of anticoagulation treatment(s) | ||||
Previscan | 1 | 1 | 3 | 5 |
Coumadine | 5 | 5 | 6 | 16 |
Fenprocoumon | . | . | 1 | 1 |
Fraxodi | . | 1 | . | 1 |
Sintrom | . | . | 1 | 1 |
Marcoumar | 2 | 1 | 2 | 5 |
Acenocoumarol | 1 | 1 | . | 2 |
Current anticoagulant administration route | ||||
Oral | 9 | 8 | 13 | 30 |
Injection | . | 1 | . | 1 |
Experience of anticoagulant self-injections | ||||
Yes | 3 | 3 | 2 | 8 |
No | 6 | 6 | 11 | 23 |
Blood test frequency | ||||
Every 1 – 2 weeks | 5 | 5 | 3 | 13 |
Every 2 – 4 weeks | 2 | 2 | 3 | 7 |
Every month | 2 | 2 | 4 | 8 |
Every 1–2 months | . | . | 3 | 3 |
Receiving an anticoagulant treatment since (year) | ||||
Range | 0.3 – 2 | 0.6 – 8 | 0.5 – 13 | 0.3 – 13 |
Mean | 1.2 | 2.3 | 5.6 | 3.3 |
Duration of anticoagulant treatment | ||||
Lifetime | 2 | 5 | 12 | 19 |
One year | . | 2 | . | 2 |
6 months | 3 | 1 | 1 | 5 |
Less than 6 months | 1 | 1 | . | 2 |
Unknown | 2 | . | . | 2 |
Finished | 1 | . | . | 1 |
OTHER CO-MORBIDITIES | ||||
Yes | 4 | 5 | 8 | 17 |
No | 5 | 4 | 5 | 14 |